Opticyte Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Opticyte General Information

Description

Developer of a cellular oximeter designed to monitor patients' health. The company's noninvasive oximeter uses optical spectroscopy to measure oxygen inside cells and facilitate early detection of shock, enabling clinicians to make treatment decisions to prevent multiple organ failure and death in patients suffering from sepsis, hemorrhage, and cardiac dysfunction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4000 Mason Road
  • Suite 300
  • Seattle, WA 98195
  • United States
+1 (206)
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 4000 Mason Road
  • Suite 300
  • Seattle, WA 98195
  • United States
+1 (206)

Opticyte Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opticyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator Completed Generating Revenue
10. Equity Crowdfunding 30-Jun-2025 Completed Generating Revenue
9. Angel (individual) 05-Dec-2024 Completed Generating Revenue
8. Later Stage VC (Series A) Cancelled Generating Revenue
7. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
6. Seed Round 01-Oct-2020 Completed Generating Revenue
5. Grant 01-May-2020 Completed Startup
4. Grant 01-Jan-2016 Completed Startup
3. Grant 01-Apr-2015 $911K Completed Startup
2. Grant 01-Jan-2015 $150K Completed Startup
To view Opticyte’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Opticyte Patents

Opticyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260114763-A1 Determining blood-oxygen level (spo2) using broadband spectra to reduce or eliminate skin-tone bias in the determined spo2 value, and/or using broadband spectra to determine pulse rate Pending 29-Oct-2024
WO-2026096679-A1 Determining blood-oxygen level (spo2) using broadband spectra to reduce or eliminate skin-tone bias in the determined spo2 value, and/or using broadband spectra to determine pulse rate Pending 29-Oct-2024
EP-4727645-A1 Determining a level of oxygenation of one or more cells Pending 15-Jun-2023
WO-2024259447-A1 Determining a level of oxygenation of one or more cells Inactive 15-Jun-2023
EP-4322852-A1 Determining a level of oxygenation of one or more cells Pending 16-Apr-2021 A61B5/0075
To view Opticyte’s complete patent history, request access »

Opticyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Opticyte Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
FBomb Angels Angel Group Minority
MedTech Innovator Accelerator/Incubator Minority
Keiretsu Capital Venture Capital Minority
Keiretsu Forum Angel Group Minority
SWAN Venture Fund Angel Group Minority
You’re viewing 5 of 9 investors. Get the full list »

Opticyte FAQs

  • When was Opticyte founded?

    Opticyte was founded in 2015.

  • Where is Opticyte headquartered?

    Opticyte is headquartered in Seattle, WA.

  • What is the size of Opticyte?

    Opticyte has 9 total employees.

  • What industry is Opticyte in?

    Opticyte’s primary industry is Monitoring Equipment.

  • Is Opticyte a private or public company?

    Opticyte is a Private company.

  • What is Opticyte’s current revenue?

    The current revenue for Opticyte is .

  • How much funding has Opticyte raised over time?

    Opticyte has raised $1.78M.

  • Who are Opticyte’s investors?

    FBomb Angels, MedTech Innovator, Keiretsu Capital, Keiretsu Forum, and SWAN Venture Fund are 5 of 9 investors who have invested in Opticyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process